NDC 54868-4535-2 - LEVOXYL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54868-4535
- Requested NDC
- 54868-4535-2
- Package NDCs from labels
- 54868-4535-1, 54868-4535-2
- Manufacturer
- Physicians Total Care, Inc.
- Effective date
- 2013-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levoxyl ® (levothyroxine sodium tablets, USP) | Physicians Total Care, Inc. | 2013-08-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54868-4535-1 | 2019-09-24 | C162847 | 48780-1 | 9350213a-44f6-c013-e053-90daa90a1393 | Levoxyl ® (levothyroxine sodium tablets, USP) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54868-4535-1 | LEVOXYL | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54868-4535 | LEVOXYL (LEVOTHYROXINE SODIUM) TABLET [PHYSICIANS TOTAL CARE, INC.] | 5 | 1 package rows | 20130820_951c6e16-7251-42ed-ac19-d8367a6aee4f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54868-4535-0 | EA - Each | 54868-4535 | b4aef346-caf3-4da3-8d9d-1925e154fab5 | 1 | 2012-07-24 |
| 54868-4535-1 | EA - Each | 54868-4535 | e84f8d98-5131-4014-927f-495343aa1e72 | 1 | 2012-07-24 |
| 54868-4535-2 | EA - Each | 54868-4535 | 2dc70794-405b-4bee-8a56-d732a9fcb6e0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31a35cb-fc54-8872-e053-2a95a90ad8e7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31ba297-e042-187a-e053-2a95a90a4861 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31d987d-6836-b4a7-e053-2a95a90a8f7b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86e74e1-0d55-8d0e-e053-6394a90a07bf | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86efc89-f784-c8bb-e053-6294a90a63c9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db9821db-3fe3-d1cf-e053-2a95a90a0252 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | da570872-94a1-4852-e053-2995a90aacb6 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | da827567-810b-624d-e053-2a95a90a9bde | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86fab39-bbd9-a51c-e053-6294a90accd0 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9dff641-ced3-bae3-e053-2a95a90a2e29 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 472ec9e7-c1db-bf8c-e063-6394a90a2c07 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Sodium Bicarbonate 10 gr | SODIUM BICARBONATE | GRAXCELL PHARMACEUTICAL, LLC | 897dbb09-fb47-4e03-8cae-bf76d48a7a03 | 2025-12-25 | Warnings | 8MDF5V39QO |
| Zegerid OTC | OMEPRAZOLE, SODIUM BICARBONATE | Riley Consumer Care LLC | 1d764fc5-8eae-4fc9-a2e9-3f1954a3ac05 | 2025-12-24 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | ProPharma Distribution | 3867f743-c2cf-a646-e063-6394a90a82e1 | 2025-12-18 | Warnings, Adverse reactions | 8MDF5V39QO |
| After Bite Advanced | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 223d1de8-7940-bbdc-e063-6294a90a51d8 | 2025-12-18 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | e3667ab1-2bd9-4e0d-8a97-f907593e7954 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | eb120047-a43b-40a4-9f55-067b1b51edda | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| SinuCleanse | SODIUM BICARBONATE, SODIUM CHLORIDE | ASCENT CONSUMER PRODUCTS, INC. | beb842fa-2373-4f21-9631-ef20ee124584 | 2025-12-10 | Warnings | 8MDF5V39QO |
| All natural Saline Packets CareOne | SODIUM BICARBONATE, SODIUM CHLORIDE | FOODHOLD U.S.A. | e32f105d-65cd-8095-e053-2995a90a9b6b | 2025-12-10 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Heartburn | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer HealthCare LLC. | 55158e50-0327-2043-e054-00144ff8d46c | 2025-12-04 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.